ASCL1 and neoplasm: found that the number of tumors with dual high expression of ASCL1 and NEUROD1 exceeds those with high NEUROD1 expression alone, suggesting the presence of distinct subgroups within the tumor that exhibit differing biological behaviors and therapeutic responses (20).